The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.<\/p>\n
1631 ET \u2013 Medical device maker Fisher & Paykel Healthcare\u2019s share price rises 4.8% to erase all of this month\u2019s losses as investors cheer an upgrade to its annual profit guidance. F&P Healthcare now expects FY 2026 net profit to total NZ$410 million-NZ$460 million, up from an earlier projection for NZ$390 million-A$440 million. It also signaled higher annual revenue of NZ$2.17 billion-NZ$2.27 billion. Jefferies analyst Vanessa Thomson says ongoing clinical changes, new products and business efficiencies drove the upgrade. Jefferies rates F&P Healthcare a buy, with a NZ$44.40\/share price target. F&P Healthcare rose to NZ$38.45 in the first half hour of Wednesday\u2019s trading. (david.winning@wsj.com<\/a>; @dwinningWSJ)<\/p>\n Copyright \u00a92025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8<\/p>\n","protected":false},"excerpt":{"rendered":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…\n","protected":false},"author":2,"featured_media":200201,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[10852,1128,110722,85833,41573,41570,13782,41565,95145,18,41571,14480,3334,135,475,474,82483,19,41586,17,3544,3521,110723,6403,82656,69291,5790,82482,27250,2900,7840,87959,9436,44285,95144,95142,26243,642,41580],"class_list":{"0":"post-200200","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-asia-pacific","9":"tag-australia","10":"tag-australia-oceania","11":"tag-ce-exclusion-filter","12":"tag-ce-industry-news-filter","13":"tag-content-types","14":"tag-corporate","15":"tag-corporate-industrial-news","16":"tag-disruptions","17":"tag-eire","18":"tag-factiva-filters","19":"tag-financial-performance","20":"tag-general-news","21":"tag-health","22":"tag-health-care","23":"tag-healthcare","24":"tag-healthcare-life-sciences","25":"tag-ie","26":"tag-industrial-news","27":"tag-ireland","28":"tag-life-sciences","29":"tag-lifestyle","30":"tag-linkendrnrealtime-linkedarticle-dnco20251125008319","31":"tag-living","32":"tag-living-lifestyle","33":"tag-mental-fitness","34":"tag-new-zealand","35":"tag-newsplus","36":"tag-oceania","37":"tag-pharmaceuticals","38":"tag-physical","39":"tag-physical-mental-fitness","40":"tag-political","41":"tag-political-general-news","42":"tag-share-price-movement","43":"tag-share-price-movement-disruptions","44":"tag-synd","45":"tag-weight-management","46":"tag-wsj-pro-wsj-com"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/200200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=200200"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/200200\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/200201"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=200200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=200200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=200200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}